Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 8
2005 17
2006 29
2007 24
2008 14
2009 20
2010 20
2011 16
2012 25
2013 23
2014 18
2015 11
2016 6
2017 9
2018 10
2019 7
2020 13
2021 6
2022 8
2023 11
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

263 results

Results by year

Filters applied: . Clear all
Page 1
Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
Cansu DÜ, Korkmaz C. Cansu DÜ, et al. Clin Rheumatol. 2023 Oct;42(10):2601-2610. doi: 10.1007/s10067-022-06446-y. Epub 2022 Nov 17. Clin Rheumatol. 2023. PMID: 36396789 Review.
Pulmonary hypertension (PH) is a clinical condition characterized by increased pulmonary arterial pressure arising from a heterogeneous range of diseases that has a deteriorating effect on the quality of life and may cause early mortality if left untreated. ...The prognosi …
Pulmonary hypertension (PH) is a clinical condition characterized by increased pulmonary arterial pressure arising from a heterogeneo …
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis.
Hoeper MM, Dwivedi K, Pausch C, Lewis RA, Olsson KM, Huscher D, Pittrow D, Grünig E, Staehler G, Vizza CD, Gall H, Distler O, Opitz C, Gibbs JSR, Delcroix M, Park DH, Ghofrani HA, Ewert R, Kaemmerer H, Kabitz HJ, Skowasch D, Behr J, Milger K, Lange TJ, Wilkens H, Seyfarth HJ, Held M, Dumitrescu D, Tsangaris I, Vonk-Noordegraaf A, Ulrich S, Klose H, Claussen M, Eisenmann S, Schmidt KH, Swift AJ, Thompson AAR, Elliot CA, Rosenkranz S, Condliffe R, Kiely DG, Halank M. Hoeper MM, et al. Lancet Respir Med. 2022 Oct;10(10):937-948. doi: 10.1016/S2213-2600(22)00097-2. Epub 2022 Jun 28. Lancet Respir Med. 2022. PMID: 35777416 Free PMC article.
BACKGROUND: Among patients meeting diagnostic criteria for idiopathic pulmonary arterial hypertension (IPAH), there is an emerging lung phenotype characterised by a low diffusion capacity for carbon monoxide (DLCO) and a smoking history. ...
BACKGROUND: Among patients meeting diagnostic criteria for idiopathic pulmonary arterial hypertension (IPAH), th …
Portopulmonary hypertension.
Mukhtar NA, Fix OK. Mukhtar NA, et al. J Clin Gastroenterol. 2011 Sep;45(8):703-10. doi: 10.1097/MCG.0b013e31820656bd. J Clin Gastroenterol. 2011. PMID: 21325952 Review.
Portopulmonary hypertension is pathologically indistinguishable from idiopathic pulmonary arterial hypertension and is characterized by the development of vasoconstriction, vascular remodeling, and thrombosis within the pulmonary vasculature. ...
Portopulmonary hypertension is pathologically indistinguishable from idiopathic pulmonary arterial hypertension …
Emerging pharmacotherapies for the treatment of pulmonary arterial hypertension.
Auth R, Klinger JR. Auth R, et al. Expert Opin Investig Drugs. 2023 Jul-Dec;32(11):1025-1042. doi: 10.1080/13543784.2023.2274439. Epub 2023 Nov 24. Expert Opin Investig Drugs. 2023. PMID: 37881882 Review.
At the same time, novel drugs targeting specific molecular pathways involved in PAH pathogenesis have been developed and are being investigated in clinical trials. This review summarizes investigational drug trials for PAH gathered from a comprehensive search using PubMed …
At the same time, novel drugs targeting specific molecular pathways involved in PAH pathogenesis have been developed and are being investiga …
Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Diagnosis, and Management.
Yandrapalli S, Tariq S, Kumar J, Aronow WS, Malekan R, Frishman WH, Lanier GM. Yandrapalli S, et al. Cardiol Rev. 2018 Mar/Apr;26(2):62-72. doi: 10.1097/CRD.0000000000000164. Cardiol Rev. 2018. PMID: 28832374 Review.
Based on available data, CTEPH is a rare disease entity occurring in a small proportion (0.5-3%) of patients after acute pulmonary embolism with an annual incidence ranging anywhere between 1 and 7 cases per million population. It is often underdiagnosed or misdiagnosed as idi …
Based on available data, CTEPH is a rare disease entity occurring in a small proportion (0.5-3%) of patients after acute pulmonary embolism …
Combined pre- and post-capillary pulmonary hypertension in left heart disease.
Riccardi M, Pagnesi M, Sciatti E, Lombardi CM, Inciardi RM, Metra M, Vizzardi E. Riccardi M, et al. Heart Fail Rev. 2023 Jan;28(1):137-148. doi: 10.1007/s10741-022-10251-9. Epub 2022 Jun 1. Heart Fail Rev. 2023. PMID: 35650331 Review.
Thanks to echocardiography parameters and newly introduced scores, more tools are available to distinguish between idiopathic pulmonary arterial hypertension and combined PH and to guide patients' management. It may be hypothesized to treat patients in …
Thanks to echocardiography parameters and newly introduced scores, more tools are available to distinguish between idiopathic pulm …
Idiopathic pulmonary arterial hypertension.
Souza R, Jardim C, Humbert M. Souza R, et al. Semin Respir Crit Care Med. 2013 Oct;34(5):560-7. doi: 10.1055/s-0033-1355439. Epub 2013 Sep 13. Semin Respir Crit Care Med. 2013. PMID: 24037625
Idiopathic pulmonary arterial hypertension (IPAH), formerly called primary pulmonary hypertension, is a rare disease (incidence and prevalence rates of approximately one and six cases per million inhabitants, respectively) with different clinical …
Idiopathic pulmonary arterial hypertension (IPAH), formerly called primary pulmonary hypertension, is a rare dis …
Idiopathic pulmonary arterial hypertension in childhood.
Haworth SG. Haworth SG. Cardiol Rev. 2010 Mar-Apr;18(2):64-6. doi: 10.1097/CRD.0b013e3181ce03df. Cardiol Rev. 2010. PMID: 20160530 Review.
The introduction of new medicines to treat pulmonary vascular disease has renewed interest in the management of children with idiopathic pulmonary arterial hypertension. We now have a practical classification of pulmonary hypertension, improved diagnos …
The introduction of new medicines to treat pulmonary vascular disease has renewed interest in the management of children with idiopathic …
Idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: similarities and differences.
Montani D, Kemp K, Dorfmuller P, Sitbon O, Simonneau G, Humbert M. Montani D, et al. Semin Respir Crit Care Med. 2009 Aug;30(4):411-20. doi: 10.1055/s-0029-1233310. Epub 2009 Jul 24. Semin Respir Crit Care Med. 2009. PMID: 19634080 Review.
Pulmonary veno-occlusive disease (PVOD) is a rare disorder and can be misdiagnosed as idiopathic pulmonary arterial hypertension (iPAH). PVOD and iPAH often share a similar clinical presentation, genetic background, and hemodynamic profile. ...
Pulmonary veno-occlusive disease (PVOD) is a rare disorder and can be misdiagnosed as idiopathic pulmonary arterial …
263 results